We help providers deliver more accessible genetic services to the patients they serve
Find out how our and genetic experts and services can help your organization
Learn more about our areas of expertise
Learn more about how we help you deliver more genetic services to more patients
We do it because we want to make precision medicine actionable to improve lives
We support hospitals and health systems, biopharmaceutical organizations, and genetic testing labs
Find out how our genetic experts can help your organization
We help you expand your genetic services to more patients to improve health outcomes
Navigate Genetic Testing and Counseling with Confidence
View our case studies to see how we’ve helped our partners achieve results.
Home » What is Familial Chylomicronemia Syndrome (FCS)?
Familial chylomicronemia syndrome (FCS) is a severe and ultra rare genetic disease, with a prevalence of approximately 1 in 1,000,000. Patients with FCS are unable to effectively breakdown dietary fats resulting in severe elevations in triglycerides in the blood, which can cause serious signs and symptoms including acute pancreatitis (which can be fatal), chronic daily abdominal pain, type 2 diabetes mellitus, hepatic steatosis, and cognitive issues (aka “brain fog”). FCS is often controlled by severely limiting dietary fat intake, which can reduce the risk of pancreatitis. Pancreatitis is a major life-threatening complication of FCS and can lead to other life-threatening conditions such as sepsis, acute respiratory distress syndrome, hypovolemic shock, and renal failure.
Additional resources for learning more about Familial Chylomicronemia Syndrome: